サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1414283

単純ヘルペスウイルス治療の世界市場レポート 2024年

Herpes Simplex Virus Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
単純ヘルペスウイルス治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

単純ヘルペスウイルス治療市場規模は近年力強く成長しています。2023年の22億4,000万米ドルから2024年には23億9,000万米ドルへと、CAGR6.6％で拡大します。過去の期間に観察された拡大は、HSV感染の有病率の増加、抗ウイルス薬の開発、薬剤の承認につながる臨床研究の進歩、患者の教育と意識向上への取り組み、性感染症（STD）予防のための世界の取り組みなどの要因によるものです。

単純ヘルペスウイルス治療市場規模は、今後数年間で力強い成長が見込まれます。2028年には年間平均成長率（CAGR）6.7％で31億米ドルに成長します。予測期間中に予想される成長は、抗ウイルス療法の進歩、予防対策への注目の高まり、ワクチン開発の可能性、遠隔医療や遠隔診察の採用、世界ヘルスへの取り組みなどに起因すると考えられます。予測期間に予想される主要動向には、ナノ技術の導入、遠隔診察のための遠隔医療の利用、自然療法やハーブ療法の探求、新生児ヘルペス予防のための戦略、抗ウイルス薬耐性のモニタリングなどが含まれます。

性感染症の有病率の増加が予想されることから、単純ヘルペスウイルス治療市場の今後の成長が見込まれます。性感染症（STDs）または性行為感染症（STIs）は、性行為を通じて感染する特定の細菌、ウイルス、またはその他の微生物への感染に起因します。単純ヘルペスウイルス（HSV）の治療は、主に尿道炎、子宮頸管炎、性器潰瘍につながる感染症などの性感染症に対処することを目的としています。米国疾病予防管理センターの2023年4月の報告書によると、米国では2020年から2021年にかけてSTD患者が増加し、その総数は250万人を超えました。特に梅毒患者は32％急増し、2021年には176,713人に達しました。したがって、性感染症の急増は単純ヘルペスウイルス治療市場を推進する重要な要因です。

都市化は単純ヘルペスウイルス治療市場成長の原動力になると予測されます。都市化は、経済発展と工業化によって促進されるプロセスであり、農村部を都市中心部に変貌させます。都市部におけるHSV治療の普及は、人口密度の向上、医療へのアクセスの改善、意識の高まりに起因しており、都市環境におけるウイルスの蔓延を抑制するためのより現実的な選択肢となっています。世界銀行グループの2023年4月の推定によると、世界人口の半分以上が都市部に居住しており、この都市人口は2045年までに1.5倍の60億人に増加すると予測されています。したがって、都市化は単純ヘルペスウイルス治療市場を牽引する重要な要因です。

2023年の単純ヘルペスウイルス治療市場で最大の地域は北米でした。アジア太平洋は、単純ヘルペスウイルス治療の世界市場レポートにおいて、予測期間中に最も急成長する地域となる見込みです。単純ヘルペスウイルス治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の単純ヘルペスウイルス治療市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の単純ヘルペスウイルス治療市場規模実績と成長、2018～2023年
  • 世界の単純ヘルペスウイルス治療市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の単純ヘルペスウイルス治療市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 単純ヘルペスウイルス-1感染症
  • 単純ヘルペスウイルス-2感染症
  • 世界の単純ヘルペスウイルス治療市場、薬剤のタイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • アシクロビル
  • バラシクロビル
  • ファムシクロビル
  • その他の薬物
  • 世界の単純ヘルペスウイルス治療市場、投与経路別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 経口
  • 注射
  • 局所
  • 世界の単純ヘルペスウイルス治療市場、ワクチン別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • シンプリリクス
  • その他のワクチン
  • 世界の単純ヘルペスウイルス治療市場、流通チャネル別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院薬局
  • ドラッグストア
  • 小売薬局
  • オンラインプロバイダー

第7章 地域と国の分析

  • 世界の単純ヘルペスウイルス治療市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の単純ヘルペスウイルス治療市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 単純ヘルペスウイルス治療市場の競合情勢
  • 単純ヘルペスウイルス治療市場の企業プロファイル
    • GlaxoSmithKline plc
    • Carlsbad Technology Inc.
    • Glenmark Pharmaceuticals Ltd.
    • Fresenius Kabi AG
    • Apotex Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

目次
Product Code: r11793

“Herpes Simplex Virus Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on herpes simplex virus treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for herpes simplex virus treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The herpes simplex virus treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Herpes Simplex Virus-1 Infection; Herpes Simplex Virus-2 Infection
  • 2) By Drug Type: Acyclovir; Valacyclovir; Famciclovir; Other Drugs
  • 3) By Route Of Administration: Oral; Injection; Topical
  • 4) By Vaccine: Simplirix; Other Vaccines
  • 5) By Distribution Channel: Hospital Pharmacies; Drug store; Retail Pharmacies; Online Providers
  • Companies Mentioned: GlaxoSmithKline plc; Carlsbad Technology Inc.; Glenmark Pharmaceuticals Ltd.; Fresenius Kabi AG; Apotex Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Herpes simplex virus treatment involves addressing infections caused by the herpes simplex virus (HSV), commonly known as herpes, which can result in painful blisters or ulcers. This treatment aims to manage the symptoms of the viral infection through the use of antiviral creams or tablets.

The main types of herpes simplex virus treatment are for herpes simplex virus-1 infection and herpes simplex virus-2 infection. Herpes simplex virus type 1 (HSV-1) belongs to the Alphaherpesviridae subfamily, characterized by a linear double-stranded DNA virus. The various drugs used for treatment include acyclovir, valacyclovir, famciclovir, and others. Treatment can be administered through oral, injection, or topical routes. Several types of vaccines, including Simplirix and others, are available and sold through various distribution channels such as hospital pharmacies, drug stores, retail pharmacies, and online providers.

The herpes simplex virus treatment market research report is one of a series of new reports from The Business Research Company that provides herpes simplex virus treatment market statistics, including herpes simplex virus treatment industry global market size, regional shares, competitors with a herpes simplex virus treatment market share, detailed herpes simplex virus treatment market segments, market trends and opportunities, and any further data you may need to thrive in the herpes simplex virus treatment industry. This herpes simplex virus treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The herpes simplex virus treatment market size has grown strongly in recent years. It will grow from $2.24 billion in 2023 to $2.39 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The expansion observed in the historical period can be attributed to factors such as the increased prevalence of HSV infections, the development of antiviral medications, advancements in clinical research leading to drug approvals, efforts in patient education and awareness, and global initiatives for sexually transmitted disease (STD) prevention.

The herpes simplex virus treatment market size is expected to see strong growth in the next few years. It will grow to $3.1 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated growth in the forecast period can be attributed to advancements in antiviral therapies, an increased focus on preventive measures, potential vaccine development, the adoption of telemedicine and remote consultations, and global health initiatives. Key trends expected in the forecast period encompass the incorporation of nanotechnology, the use of telemedicine for remote consultations, exploration of natural and herbal therapies, strategies for neonatal herpes prevention, and monitoring for antiviral drug resistance.

The anticipated rise in the prevalence of sexually transmitted infections is poised to drive the growth of the herpes simplex virus treatment market in the future. Sexually transmitted diseases (STDs) or sexually transmitted infections (STIs) result from infections with specific bacteria, viruses, or other microorganisms transmitted through sexual intercourse. The treatment of the herpes simplex virus (HSV) is primarily aimed at addressing sexually transmitted illnesses such as urethritis, cervicitis, and infections leading to genital ulcers. According to the Center for Disease Control and Prevention's April 2023 report, the USA witnessed an increase in STD cases from 2020 to 2021, totaling over 2.5 million. Notably, syphilis cases surged by 32%, reaching 176,713 in 2021. Hence, the upsurge in sexually transmitted infections is a key factor propelling the herpes simplex virus treatment market.

Urbanization is expected to be a driving force behind the growth of the herpes simplex virus treatment market. Urbanization, a process fueled by economic development and industrialization, transforms rural areas into urban centers. The prevalence of HSV treatment in urban populations is attributed to higher population density, improved healthcare accessibility, and increased awareness, making it a more viable option for controlling the virus's spread in urban settings. According to the World Bank Group's April 2023 estimates, over half of the global population resides in urban areas, and this urban population is projected to grow to 6 billion, marking a 1.5 times increase by 2045. Therefore, urbanization is a significant factor driving the herpes simplex virus treatment market.

A notable trend gaining traction in the herpes simplex virus treatment market is the innovation of HSV treatments. Major companies in the market are actively engaged in developing new treatments and drugs to maintain their market position. For instance, in October 2022, Replay Therapeutics, a US-based genome writing company, introduced Eudora, its first HSV gene therapy company focusing on retinal eye disease. Eudora is the first product using synHSVTM, a high-payload-capacity HSV delivery vector, within Replay's distinct corporate structure that separates the development of technological and medicinal products. This innovative approach aims to address monogenic brain, skin, and muscle illnesses using big DNA gene therapy.

Leading companies in the herpes simplex virus treatment market are directing their efforts toward developing advanced tests, such as chip-based RT-PCR tests, to meet the demand for efficient diagnostic solutions and enhance market profitability. The chip-based RT-PCR test utilizes microchip technology for rapid and efficient nucleic acid amplification through reverse transcription-polymerase chain reaction. In January 2023, Molbio Diagnostics, an India-based molecular diagnostics manufacturer, launched Truenat HSV 1/2, a chip-based RT-PCR test approved by CDSCO for swift herpes diagnosis. This test, compatible with the Truelab infrastructure, provides sample-to-results in an hour without additional setup, employing real-time PCR technology to distinguish between HSV-1 and HSV-2, aiding in the prompt detection of oral and genital herpes.

In April 2023, SK Capital acquired Apotex Pharmaceutical Holdings Inc for an undisclosed amount, aiming to leverage Apotex's iconic brand, extensive product portfolio, international presence, and skilled team to establish itself as a leading global player in the pharmaceutical industry. Apotex Pharmaceutical Holdings, based in Canada, is a pharmaceutical company providing tablets for herpes virus treatment.

Major companies operating in the herpes simplex virus treatment market report are GlaxoSmithKline plc, Carlsbad Technology Inc., Glenmark Pharmaceuticals Ltd., Fresenius Kabi AG, Apotex Inc., Mylan N.V., Teva Pharmaceuticals Industries Ltd., Sanofi S.A., Novartis AG, Zydus Pharmaceuticals Inc., Abbott Laboratories, Amneal Pharmaceuticals Inc., Pfizer Inc., Viatris Inc., Agenus Inc., Merck KGaA, Chimerix Inc., Avet Pharmaceuticals Inc., EPI Health LLC, Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Johnson & Johnson, AbbVie Inc., AstraZeneca plc, Gilead Sciences Inc., Bayer AG, Eli Lilly and Company, BioCryst Pharmaceuticals Inc., AiCuris Anti-infective Cures GmbH, CureVac AG

North America was the largest region in the herpes simplex virus treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global herpes simplex virus treatment market report during the forecast period. The regions covered in the herpes simplex virus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the herpes simplex virus treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The herpes simplex virus treatment market consists of sales of docosanol and penciclovir. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Herpes Simplex Virus Treatment Market Characteristics

3. Herpes Simplex Virus Treatment Market Trends And Strategies

4. Herpes Simplex Virus Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Herpes Simplex Virus Treatment Market Size and Growth

  • 5.1. Global Herpes Simplex Virus Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Herpes Simplex Virus Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Herpes Simplex Virus Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Herpes Simplex Virus Treatment Market Segmentation

  • 6.1. Global Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Herpes Simplex Virus-1 Infection
  • Herpes Simplex Virus-2 Infection
  • 6.2. Global Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Acyclovir
  • Valacyclovir
  • Famciclovir
  • Other Drugs
  • 6.3. Global Herpes Simplex Virus Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Injection
  • Topical
  • 6.4. Global Herpes Simplex Virus Treatment Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Simplirix
  • Other Vaccines
  • 6.5. Global Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Drug store
  • Retail Pharmacies
  • Online Providers

7. Herpes Simplex Virus Treatment Market Regional And Country Analysis

  • 7.1. Global Herpes Simplex Virus Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Herpes Simplex Virus Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Herpes Simplex Virus Treatment Market

  • 8.1. Asia-Pacific Herpes Simplex Virus Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Herpes Simplex Virus Treatment Market

  • 9.1. China Herpes Simplex Virus Treatment Market Overview
  • 9.2. China Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Herpes Simplex Virus Treatment Market

  • 10.1. India Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Herpes Simplex Virus Treatment Market

  • 11.1. Japan Herpes Simplex Virus Treatment Market Overview
  • 11.2. Japan Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Herpes Simplex Virus Treatment Market

  • 12.1. Australia Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Herpes Simplex Virus Treatment Market

  • 13.1. Indonesia Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Herpes Simplex Virus Treatment Market

  • 14.1. South Korea Herpes Simplex Virus Treatment Market Overview
  • 14.2. South Korea Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Herpes Simplex Virus Treatment Market

  • 15.1. Western Europe Herpes Simplex Virus Treatment Market Overview
  • 15.2. Western Europe Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Herpes Simplex Virus Treatment Market

  • 16.1. UK Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Herpes Simplex Virus Treatment Market

  • 17.1. Germany Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Herpes Simplex Virus Treatment Market

  • 18.1. France Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Herpes Simplex Virus Treatment Market

  • 19.1. Italy Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Herpes Simplex Virus Treatment Market

  • 20.1. Spain Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Herpes Simplex Virus Treatment Market

  • 21.1. Eastern Europe Herpes Simplex Virus Treatment Market Overview
  • 21.2. Eastern Europe Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Herpes Simplex Virus Treatment Market

  • 22.1. Russia Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Herpes Simplex Virus Treatment Market

  • 23.1. North America Herpes Simplex Virus Treatment Market Overview
  • 23.2. North America Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Herpes Simplex Virus Treatment Market

  • 24.1. USA Herpes Simplex Virus Treatment Market Overview
  • 24.2. USA Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Herpes Simplex Virus Treatment Market

  • 25.1. Canada Herpes Simplex Virus Treatment Market Overview
  • 25.2. Canada Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Herpes Simplex Virus Treatment Market

  • 26.1. South America Herpes Simplex Virus Treatment Market Overview
  • 26.2. South America Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Herpes Simplex Virus Treatment Market

  • 27.1. Brazil Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Herpes Simplex Virus Treatment Market

  • 28.1. Middle East Herpes Simplex Virus Treatment Market Overview
  • 28.2. Middle East Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Herpes Simplex Virus Treatment Market

  • 29.1. Africa Herpes Simplex Virus Treatment Market Overview
  • 29.2. Africa Herpes Simplex Virus Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Herpes Simplex Virus Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Herpes Simplex Virus Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Herpes Simplex Virus Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Herpes Simplex Virus Treatment Market Competitive Landscape
  • 30.2. Herpes Simplex Virus Treatment Market Company Profiles
    • 30.2.1. GlaxoSmithKline plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Carlsbad Technology Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Glenmark Pharmaceuticals Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Fresenius Kabi AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Apotex Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Herpes Simplex Virus Treatment Market Competitive Benchmarking

32. Global Herpes Simplex Virus Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Herpes Simplex Virus Treatment Market

34. Herpes Simplex Virus Treatment Market Future Outlook and Potential Analysis

  • 34.1 Herpes Simplex Virus Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Herpes Simplex Virus Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Herpes Simplex Virus Treatment Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer